7 results
2019 EULAR recommendations for thrombosis in (Antiphospholipid Syndrome) APS
Venous Thrombosis - Arterial Thrombosis
INR Target
Duration
Recurrence

Dr. Laurent ARNAUD
Syndrome) APS ... #Syndrome #APS ... management #EULAR2019 #guidelines ... #rheumatology # ... hematology #treatment
Antiphospholipid Syndrome (APS)
APS is a rare autoimmune disorder characterized by recurring blood clots resulting from antibodies
Antiphospholipid ... microvasculature Antiphospholipid ... to be present Treatment ... (EULAR Guidelines ... anticoagulation #guidelines
2019 EULAR Recommendations - Obstetrics Management in (Antiphospholipid Syndrome) APS
Previous Thrombosis?
Previous Pregnancy Complications?

Dr. Laurent ARNAUD @Lupusreference

#obstetrics
Syndrome) APS ... #Syndrome #APS ... management #EULAR2019 #guidelines ... #rheumatology # ... obgyn #treatment
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
- ACR/VF 2021 Guidelines ... • Visual Symptoms ... Without Visual Symptoms ... Vasculitis #Management #Treatment ... #algorithm #rheumatology
Leukostasis vs Tumor Lysis Syndrome
Leukostasis:
 • Pathophysiology: Large, immature blasts and high WBC count cause hyperviscosity
Dehydration • Symptoms ... : - Neuro: AMS ... changes, stroke symptoms ... organ damage • Treatment ... diagnosis #management #hematology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Incidence: common in APL ... Triggers: ATRA treatment ... Diagnosis: >3 symptoms ... Renal Failure Treatment ... diagnosis #management #hematology
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
syndromes current treatment ... collectively have a high symptom ... disease-associated symptoms ... Network (NCCN) guidelines ... #algorithm #hematology